Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.

M F Saettone, P Chetoni, L Cappanera, U Conte, U Finne, K Järvinen, J Salivirta, A Urtti
{"title":"Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.","authors":"M F Saettone,&nbsp;P Chetoni,&nbsp;L Cappanera,&nbsp;U Conte,&nbsp;U Finne,&nbsp;K Järvinen,&nbsp;J Salivirta,&nbsp;A Urtti","doi":"10.1089/jop.1993.9.1","DOIUrl":null,"url":null,"abstract":"<p><p>The object of this study was to test whether flat, circular ophthalmic inserts releasing drug only from one side, would show improved activity parameters and reduced systemic absorption. To this purpose, uncoated and one-side coated hydroxypropylcellulose inserts containing timolol were prepared and evaluated. An acrylic copolymer (Eudragit RS) was used as coating material. Timolol release from inserts was studied both in vitro and in vivo. Timolol release in vitro from the coated inserts was much slower than from the uncoated ones, due to the smaller releasing surface area. Compared with timolol eyedrops (0.5%, 50 microliters), administration of 250 micrograms of timolol in uncoated or coated inserts produced a significantly greater hypotensive effect at 6 and 8 hr post instillation in rabbits with artificially increased intraocular pressure. The coated inserts containing 62.5 micrograms of timolol antagonised isoproterenol-induced ocular hypotension significantly more than timolol eyedrops (0.5%, 12.5 microliters) and uncoated inserts containing 62.5 micrograms of timolol. Both uncoated and coated inserts provided a significant sustaining of timolol release in tear fluid and decreased systemic peak concentrations of timolol with respect to the eyedrop control. However, one-side coated inserts failed to show significant improvements with respect to the uncoated samples.</p>","PeriodicalId":16638,"journal":{"name":"Journal of ocular pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/jop.1993.9.1","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ocular pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/jop.1993.9.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

The object of this study was to test whether flat, circular ophthalmic inserts releasing drug only from one side, would show improved activity parameters and reduced systemic absorption. To this purpose, uncoated and one-side coated hydroxypropylcellulose inserts containing timolol were prepared and evaluated. An acrylic copolymer (Eudragit RS) was used as coating material. Timolol release from inserts was studied both in vitro and in vivo. Timolol release in vitro from the coated inserts was much slower than from the uncoated ones, due to the smaller releasing surface area. Compared with timolol eyedrops (0.5%, 50 microliters), administration of 250 micrograms of timolol in uncoated or coated inserts produced a significantly greater hypotensive effect at 6 and 8 hr post instillation in rabbits with artificially increased intraocular pressure. The coated inserts containing 62.5 micrograms of timolol antagonised isoproterenol-induced ocular hypotension significantly more than timolol eyedrops (0.5%, 12.5 microliters) and uncoated inserts containing 62.5 micrograms of timolol. Both uncoated and coated inserts provided a significant sustaining of timolol release in tear fluid and decreased systemic peak concentrations of timolol with respect to the eyedrop control. However, one-side coated inserts failed to show significant improvements with respect to the uncoated samples.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
给药后替马洛尔的眼内压降低和全身吸收。
本研究的目的是测试仅从一侧释放药物的扁平圆形眼科植入物是否会改善活性参数并减少全身吸收。为此,制备了含噻莫洛尔的未涂覆和单侧涂覆羟丙基纤维素插入物,并对其进行了评价。采用丙烯酸共聚物(Eudragit RS)作为涂层材料。研究了替马洛尔在体内和体外的释放。由于释放表面积较小,包被植入物的替莫洛尔体外释放速度比未包被植入物慢得多。与替马洛尔滴眼液(0.5%,50微升)相比,在人工升高眼压的家兔中,250微克的替马洛尔滴眼液在未涂覆或涂覆的植入物中,在注射后6和8小时产生显著更大的降压效果。含有62.5微克噻洛尔的涂层插入物对异丙肾上腺醇诱导的低血压的对抗作用明显优于噻洛尔滴眼液(0.5%,12.5微升)和含有62.5微克噻洛尔的未涂层插入物。与眼药水对照相比,未涂覆和涂覆的植入物均能显著维持噻洛尔在泪液中的释放,并降低噻洛尔的全身峰值浓度。然而,与未涂覆的样品相比,单面涂覆的刀片没有显示出显著的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The effect of pilocarpine on ocular levobunolol absorption from ophthalmic solutions. Prejunctional alpha 2-adrenoceptors and adenylyl cyclase regulation in the rabbit iris-ciliary body. Inhibition of cell adhesion to lens capsule by LCM 1910, an RGD-derived peptide. Ocular pharmacokinetics of orally administered azithromycin in rabbits. The presence of L-carnitine in ocular tissues of the rabbit.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1